Skip to main content
logo
Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
14.00
-3.80 (-21.35%)
At close: Jul 22, 2025

Altair Engineering Revenue

Teva Pharmaceutical Industries had revenue of $4.18B in the quarter ending June 30, 2025, with 0.29% growth. This brings the company's revenue in the last twelve months to $16.63B, up 2.07% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.

Revenue (ttm)
16.63B
Revenue Growth
+2.07%
P/S Ratio
1.12
Revenue / Employee
449.41K
Employees
35,686
Market Cap
18.69B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Veradigm588.02M
Tian'an Technology Group1.78M
Elite Pharmaceuticals84.04M
Glass House Brands215.62M
Northwest Biotherapeutics1.47M
American Oncology Network1.76B
Silence Therapeutics27.70M
BioStem Technologies332.45M
Revenue Rankings

Teva Pharmaceutical Industries News

More News